QTTB
Price
$2.57
Change
+$0.14 (+5.76%)
Updated
Feb 21 closing price
Capitalization
31.3M
STOK
Price
$8.33
Change
-$0.41 (-4.69%)
Updated
Feb 21, 04:59 PM (EDT)
Capitalization
439.63M
11 days until earnings call
Ad is loading...

QTTB vs STOK

Header iconQTTB vs STOK Comparison
Open Charts QTTB vs STOKBanner chart's image
Q32 Bio
Price$2.57
Change+$0.14 (+5.76%)
Volume$450.29K
Capitalization31.3M
Stoke Therapeutics
Price$8.33
Change-$0.41 (-4.69%)
Volume$47.28K
Capitalization439.63M
QTTB vs STOK Comparison Chart
Loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QTTB vs. STOK commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTTB is a Hold and STOK is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (QTTB: $2.43 vs. STOK: $8.74)
Brand notoriety: QTTB and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QTTB: 69% vs. STOK: 190%
Market capitalization -- QTTB: $31.3M vs. STOK: $439.63M
QTTB [@Biotechnology] is valued at $31.3M. STOK’s [@Biotechnology] market capitalization is $439.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTTB’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • QTTB’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, both QTTB and STOK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTTB’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • QTTB’s TA Score: 4 bullish, 3 bearish.
  • STOK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, QTTB is a better buy in the short-term than STOK.

Price Growth

QTTB (@Biotechnology) experienced а -9.33% price change this week, while STOK (@Biotechnology) price change was -17.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

QTTB is expected to report earnings on May 13, 2024.

STOK is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($440M) has a higher market cap than QTTB($31.3M). STOK YTD gains are higher at: -20.762 vs. QTTB (-29.360). STOK has more cash in the bank: 239M vs. QTTB (89.1M). STOK has less debt than QTTB: STOK (2.3M) vs QTTB (19.4M).
QTTBSTOKQTTB / STOK
Capitalization31.3M440M7%
EBITDAN/A-115.03M-
Gain YTD-29.360-20.762141%
P/E RatioN/AN/A-
RevenueN/A16.7M-
Total Cash89.1M239M37%
Total Debt19.4M2.3M844%
FUNDAMENTALS RATINGS
QTTB: Fundamental Ratings
QTTB
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QTTBSTOK
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGUAX14.53N/A
N/A
Virtus Duff & Phelps Global Infras A
GTDDX34.01N/A
N/A
Invesco EQV Emerging Markets All Cap A
EXHAX26.12N/A
N/A
Manning & Napier Pro-Blend Max Term S
FCDCX31.41N/A
N/A
Fidelity Advisor Stock Selector Sm Cp C
FIKKX10.81N/A
N/A
Fidelity Advisor Global Real Estate Z

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with MESO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then MESO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
+0.41%
MESO - QTTB
50%
Loosely correlated
-1.09%
STOK - QTTB
46%
Loosely correlated
-6.02%
CLRB - QTTB
39%
Loosely correlated
+1.03%
ENTA - QTTB
31%
Poorly correlated
+0.96%
STRO - QTTB
28%
Poorly correlated
-2.14%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with STRO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-6.02%
STRO - STOK
51%
Loosely correlated
-2.14%
NUVB - STOK
46%
Loosely correlated
-1.30%
QTTB - STOK
45%
Loosely correlated
+0.41%
ROIV - STOK
39%
Loosely correlated
+0.47%
DNLI - STOK
37%
Loosely correlated
-2.88%
More